Emergent BioSolutions Completes Acquisition of Specialty Vaccines Company PaxVax
October 04, 2018 18:27 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has completed its acquisition of PaxVax, a company focused on developing,...